Literature DB >> 21525340

Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.

Sachin Kumar1, Baibaswata Nayak, Peter L Collins, Siba K Samal.   

Abstract

Newcastle disease virus (NDV) belongs to serotype 1 of the avian paramyxoviruses (APMV-1) and causes severe disease in chickens. Current live attenuated NDV vaccines are not fully satisfactory. An alternative is to use a viral vector vaccine that infects chickens but does not cause disease. APMV serotype 3 infects a wide variety of avian species but does not cause any apparent disease in chickens. In this study, we constructed a reverse-genetics system for recovery of infectious APMV-3 strain Netherlands from cloned cDNAs. Two recombinant viruses, rAPMV3-F and rAPMV3-HN, were generated expressing the NDV fusion (F) and hemagglutinin-neuraminidase (HN) proteins, respectively, from added genes. These viruses were used to immunize 2-week-old chickens by the oculonasal route in order to evaluate the contribution of each protein to the induction of NDV-specific neutralizing antibodies and protective immunity. Each virus induced high titers of NDV-specific hemagglutination inhibition and serum neutralizing antibodies, but the response to F protein was greater. Protective immunity was evaluated by challenging the immunized birds 21 days later with virulent NDV via the oculonasal, intramuscular, or intravenous route. With oculonasal or intramuscular challenge, all three recombinant viruses (rAPMV3, rAPMV3-F, and rAPMV3-HN) were protective, while all unvaccinated birds succumbed to death. These results indicated that rAPMV3 alone can provide cross-protection against NDV challenge. However, with intravenous challenge, birds immunized with rAPMV3 were not protected, whereas birds immunized with rAPMV3-F alone or in combination with rAPMV3-HN were completely protected, and birds immunized with rAPMV3-HN alone were partially protected. These results indicate that the NDV F and HN proteins are independent neutralization and protective antigens, but the contribution by F is greater. rAMPV3 represents an avirulent vaccine vector that can be used against NDV and other poultry pathogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525340      PMCID: PMC3126493          DOI: 10.1128/JVI.00367-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Studies on a virus isolated from the brain of a parakeet (Neophema sp).

Authors:  T Smit; P R Rondhuis
Journal:  Avian Pathol       Date:  1976       Impact factor: 3.378

Review 2.  Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes.

Authors:  K K Conzelmann
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

Review 3.  Molecular biology of Newcastle disease virus.

Authors:  Y Nagai; M Hamaguchi; T Toyoda
Journal:  Prog Vet Microbiol Immunol       Date:  1989

4.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Relationship of parakeet/Netherlands/449/75 virus to other avian paramyxoviruses.

Authors:  D J Alexander; N J Chettle
Journal:  Res Vet Sci       Date:  1978-07       Impact factor: 2.534

6.  Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan.

Authors:  L Yu; Z Wang; Y Jiang; L Chang; J Kwang
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses.

Authors:  R Ogawa; N Yanagida; S Saeki; S Saito; S Ohkawa; H Gotoh; K Kodama; K Kamogawa; K Sawaguchi; Y Iritani
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

8.  Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3.

Authors:  Ingrid Beck; Helga Gerlach; E Burkhardt; E F Kaleta
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

9.  Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses.

Authors:  Sa Xiao; Anandan Paldurai; Baibaswata Nayak; Madhuri Subbiah; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

10.  Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses.

Authors:  Elena Carnero; Wenjing Li; Antonio V Borderia; Bruno Moltedo; Thomas Moran; Adolfo García-Sastre
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

View more
  24 in total

1.  Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals.

Authors:  Jae-Keun Park; Dong-Hun Lee; Seong-Su Yuk; Erdene-Ochir Tseren-Ochir; Jung-Hoon Kwon; Jin-Yong Noh; Byoung-Yoon Kim; Soo-Won Choi; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

2.  Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.

Authors:  Moanaro Biswas; John B Johnson; Sandeep R P Kumar; Griffith D Parks; Subbiah Elankumarana; Elankumaran Subbiah
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

3.  Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

4.  Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens.

Authors:  Sa Xiao; Sunil K Khattar; Madhuri Subbiah; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

5.  A Novel Cre Recombinase-Mediated In Vivo Minicircle DNA (CRIM) Vaccine Provides Partial Protection against Newcastle Disease Virus.

Authors:  Yanlong Jiang; Xing Gao; Ke Xu; Jianzhong Wang; Haibin Huang; Chunwei Shi; Wentao Yang; Yuanhuan Kang; Roy Curtiss; Guilian Yang; Chunfeng Wang
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

6.  Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10.

Authors:  Yan Zhao; Zongxi Han; Xiaocai Zhang; Xuemei Zhang; Junfeng Sun; Deying Ma; Shengwang Liu
Journal:  Virus Genes       Date:  2020-10-03       Impact factor: 2.332

7.  Evaluation of the genetic diversity of avian paramyxovirus type 4.

Authors:  Baibaswata Nayak; Shreeraj Nayak; Anandan Paldurai; Sachin Kumar; Roberta De Nardi; Calogero Terregino; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2012-11-21       Impact factor: 3.303

8.  Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.

Authors:  John N Mason; Husni Elbahesh; Charles J Russell
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

9.  Comprehensive Analysis and Characterization of Linear Antigenic Domains on HN Protein from Genotype VII Newcastle Disease Virus Using Yeast Surface Display System.

Authors:  Tao Li; Gaoling Wang; Bingtian Shi; Peixin Liu; Wei Si; Bin Wang; Li Jiang; Lunjiang Zhou; Jinsheng Xiu; Henggui Liu
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

10.  Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques.

Authors:  Sunil K Khattar; Baibaswata Nayak; Shin-Hee Kim; Sa Xiao; Sweety Samal; Anandan Paldurai; Ursula J Buchholz; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.